New drug ME3241 enters first human safety tests
Knowledge-focused
Recruiting now
This early-stage trial is testing a new drug called ME3241 in 104 healthy adults to see if it is safe and how the body handles it. Participants will receive either the drug or a placebo by infusion, and researchers will monitor for side effects and measure drug levels in the bloo…
Phase: PHASE1 • Sponsor: Meiji Pharma USA Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC